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Abstract
Objective: To investigate the role of three distinct symptoms of heart-focused anxiety (cardio-protective avoidance,
heart-focused attention, and fear about heart sensations) in relation to general anxiety, depression and physical health
in patients referred to specialized cardio-genetics outpatient clinics in Norway for genetic investigation and counseling.
Methods: Participants were 126 patients (mean age 45 years, 53.5% women). All patients were at higher risk than
the average person for serious arrhythmias and sudden cardiac death (SCD) because of a personal or a family
history of an inherited cardiac disorder (familial long QT syndrome or hypertrophic cardiomyopathy). Patients filled
in, Hospital Anxiety and Depression Scale, Short-Form 36 Health Survey, and Cardiac Anxiety Questionnaire, two
weeks before the scheduled counseling session.
Results: The patients experienced higher levels of general anxiety than expected in the general population (mean
difference 1.1 (p < 0.01)). Hierarchical regression analyses showed that avoidance and fear was independently
related to general anxiety, depression, and physical health beyond relevant demographic covariates (age, gender,
having children) and clinical variables (clinical diagnosis, and a recent SCD in the family). In addition to heart-
focused anxiety, having a clinical diagnosis was of importance for physical health, whereas a recent SCD in the
family was independently related to general anxiety and depression, regardless of disease status.
Conclusion: Avoidance and fear may be potentially modifiable symptoms. Because these distinct symptoms may
have important roles in determining general anxiety, depression and physical health in at-risk individuals of
inherited cardiac disorders, the present findings may have implications for the further development of genetic
counseling for this patient group.
Keywords: Anxiety, Depression, Physical Health, Heart-focused anxiety, Long QT syndrome, Hypertrophic
Cardiomyopathy
Introduction
Long QT syndrome (LQTS) and hypertrophic cardio-
myopathy (HCM) are cardiac disorders that can cause
syncope, palpitations, serious arrhythmias and sudden
cardiac death (SCD) [1-3]. This health threat may cause
fearful reactions to cardiac-related stimuli and sensa-
tions in patients with familial LQTS and familial HCM.
It is likely that this health threat influence not only
individuals that are diagnosed with LQTS or HCM, but
also their relatives at risk. Familial LQTS and familial
HCM are genetic disorders caused by gene mutations
inherited in an autosomal dominant fashion. Children,
siblings, and parents of affected patients have 50% risk
of having the same gene mutation predisposing for
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LQTS or HCM. The possibility for molecular genetics
investigation in affected individuals (patients with a
diagnosis) and their relatives (patients at genetic risk)
represents a challenge in the genetic counseling session
with respect to information, education, and especially
psychosocial support, due to the lack of systematic
knowledge of how these patients are affected by living
with familial LQTS or familial HCM.
While HCM is a quite common genetic disease affect-
ing one in 500 people [4], LQTS affects approximately
one in 2500 [1]. LQTS is an ion channel disease leading
to a prolonged QT interval with an increased propensity
to ventricular tachycardia manifesting as torsade de
pointes [5,6]. HCM is defined by the presence of
increased ventricular wall thickness or mass, having
ruled out hypertension or a valve disease [2]. In addition
to the risk of arrhythmia and syncope, HCM can give
dyspnoea, chest pain, and exertional angina [7]
The cardiac symptoms manifesting in these patients
can lead to proper management of the disease and pre-
ventive measures, such as medication (beta blockers for
LQTS), devices (implantable cardioverter defibrillators
for LQTS and HCM), and lifestyle modifications (restric-
tions of intense sports for LQTS and HCM) [8]. Because
of the reduced penetrance and variable expression of
these diseases, a substantial proportion of the individuals
will never actually experience manifested disease [9,10].
The management of these disorders is therefore compli-
cated for the caregivers, creating a lot of uncertainty and
distress when interpreting signs and symptoms for the
individuals at risk [11,12]. In addition, information of
being at risk of a possible life-threatening cardiac disor-
der and experiencing sudden cardiac death in the family
may create a burdensome life uncertainty [13].
Research based on patient-reported outcomes in at-
risk individuals with familial LQTS or familial HCM is
scarce and more is needed in order to understand the
impact of living with the risk of serious arrhythmias and
sudden cardiac death, also to identify possibilities for
intervention. In previous reports, the elevated anxiety
and distress levels among individuals with familial LQTS
have been measured in parents in relation to genetic test
results of their children [14,15]. In adult HCM patients,
living with HCM has been reported to be associated
with raised levels of anxiety and depression and
decreased levels of physical and mental health as com-
pared to the general population [16], while mutation
carriers at risk have been found to be no different than
the general population. However, experiencing symp-
toms and having a higher perceived risk of symptoms
have been reported to contribute to poorer physical and
mental health in HCM mutation carriers [11].
Given the potential serious consequences of both car-
diac disorders, heart-focused anxiety may occur in the
patients attending genetic counseling. Heart-focused
anxiety, defined as a fear of cardiac-related events and
sensations based on presumed harmful consequences (i.
e. serious arrhythmia, sudden cardiac death) can be
measured by the Cardiac Anxiety Questionnaire (CAQ)
[17]. Symptoms indicative of heart-focused anxiety is
cardio- protective avoidance behavior to minimize car-
diac symptoms or complications, increased levels of
heart-focused attention and monitoring of cardiac
related stimuli, and fear and worries about heart-sensa-
tions and functioning. Higher degrees of these symp-
toms indicate higher degrees of heart-focused anxiety
[17-19]. Such fearful symptoms may contribute in rais-
ing levels of general anxiety and depression, and influ-
ence patient-reported physical health beyond the effects
of relevant socio-demographic and clinical variables pre-
viously shown to be common confounders of these
patient-reported outcomes [11,12,14-16]. In earlier stu-
dies, high levels of heart-focused anxiety have been
reported in patients with a heart-disease, but also in
patients without a heart-disease [18-21], chest pain
intensity has been predicted by heart-focused attention
and fear in patients with coronary disease [22], and in
patients undergoing cardiac surgery, heart-focused anxi-
ety has been shown to be significantly correlated with
increased symptoms of anxiety and depression and
lower health-related quality of life [20]. In the present
population heart-focused anxiety have been found to be
higher in patients with a clinical diagnosis of LQTS or a
clinical diagnosis of HCM as compared to patients at
genetic risk [23]. However, to our knowledge, the role of
the distinct symptoms of heart-focused anxiety (avoid-
ance, attention and fear) in relation to general anxiety,
depression and physical health has never been investi-
gated in individuals with familial LQTS or familial
HCM, thus making this our overall aim. On the issue of
how to increase our competence on the LQTS or HCM
patients who seek genetic counseling and to address our
overall aim, we therefore investigated (i) these patients’
level of general anxiety, depression and physical health
and compared the scores to expected scores of the gen-
eral population, (ii) the scores of general anxiety,
depression, physical health, and heart-focused anxiety
(avoidance, attention, fear) in patients referred because
of familial LQTS as compared to the scores of patients
referred because of familial HCM, and (iii) the role of
avoidance, attention, and fear symptoms in relation to
general anxiety, depression, and physical health in the
total sample.
It was hypothesized that the patients general anxiety
and depression scores would be elevated and that physi-
cal health would be poorer compared to the expected
scores of the general population, and further that the
levels of general anxiety and depression and heart-
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focused anxiety (avoidance, attention, fear) would be
lower, and that the physical health would be better in
patients referred for familial LQTS as compared to
familial HCM, since HCM patients often exhibit more
debilitating symptoms. Finally, it was hypothesized that
higher scores of avoidance, attention and fear symptoms
would significantly and uniquely be related to (1) higher
level of general anxiety, (2) higher level of depression,
and (3) poorer physical health. In all models it was
expected that the three distinct symptoms of heart-
focused anxiety would be significant beyond demo-
graphic covariates (gender, age, having children) and
clinical variables (clinical diagnosis of either LQTS or
HCM, and a recent SCD in the family).
Methods
Participants
The participants comprised patients with the risk of ser-
ious arrhythmia and sudden cardiac death, because of
familial LQTS or familial HCM. Patients with a personal
history (with diagnosis) or a family history of LQTS or
HCM (at genetic risk), and who were consecutively
referred or self-referred to genetic counseling at the
medical genetic departments in Bergen, Trondheim, or
Oslo during the period 2005 through 2007 were eligible
for the study. One hundred and seventy-three patients
that were not previously genetic tested were asked to
participate in the study. Of these, 35 did not consent to
participate and 7 did not return the questionnaire. One
did not attend genetic counseling, one did not fill out
relevant questions in questionnaire, and 3 patients were
not included due to administrative failure, leaving 126
(72.8%) patients included in the analyses.
Procedure
Participants filled in the questionnaires with information
on socio-demographic variables, and measuring general
anxiety and depression, physical health, and symptoms
of heart-focused anxiety (avoidance, attention, and fear),
whereas information about diagnosis was obtained from
the medical records. Information about the study and a
consent form was mailed to the patient together with
the questionnaire 2-4 weeks before the genetic counsel-
ing. The participants received one reminder. The study
was approved by the Regional Committee for Medical
Research Ethics in Western Norway in September 2004.
Measures
General anxiety and depression
The Hospital Anxiety and Depression Scale (HADS)
measures anxiety and depression on two subscales;
HADS-anxiety (7 items), and HADS-depression (7
items) [24]. A higher score means a higher level of gen-
eral anxiety or depression (scores ranging from 0-21). It
is well suited as a screening tool for general anxiety and
depression, also in HCM patients, with a cut-off score
of 8 to detect clinical cases [25].
Physical health
The Short Form-36 Health Survey (SF-36) is a self-report
questionnaire that measures health status domains (0 =
worst health state; 100 = best health state) on eight sub-
scales, where physical functioning, role limitation-physi-
cal, bodily pain and general health are mainly consid-
ered physical health domains and vitality, social
functioning, role limitation-emotional and mental health
are considered mental health domains. The physical
health domains form the basis to calculate a physical
component summary (PCS) that becomes an overall
assessment of physical health which includes both func-
tioning and evaluation of one’s ability to perform physi-
cal activity. The PCS is standardized for the general
population with a mean score of 50 and a 10 points
standard deviation. The questionnaire is generic and
multidimensional, and suitable for administration to
large populations and also to patient subgroups. Its pur-
pose is to be a measure of health status or health out-
come in cross-sectional and longitudinal studies [26,27].
The SF-36 is a reliable and valid measure across studies
all over the world, and the Norwegian version exhibits
satisfactory psychometric properties [28].
Heart-focused anxiety
The Cardiac Anxiety Questionnaire (CAQ) measures
heart-focused anxiety in patients with and without heart
diseases or cardiac symptoms [17]. It consists of 18
items, and the three subscales; avoidance, attention, and
fear may be regarded as the patients’ fearful symptoms
of heart-focused anxiety to cardiac-related stimuli or
sensations based on the belief that they will lead to
negative consequences. Each item is rated on a 5-point
Likert scale; with higher scores indicating higher levels
of heart-focused anxiety. The questionnaire was trans-
lated to Norwegian by a professional translator, using a
forward and backward translation procedure.
Socio-demographic variables and diagnosis of LQTS and
HCM
Data were obtained on gender, age, having children,
SCD in first or second degree relatives, recent SCD in
the family, and clinical diagnosis vs. genetic risk of
LQTS or HCM. Recent SCD was defined as cardiac
death in a relative in the last year.
The general population
Expected scores of general anxiety and depression were
calculated based on the normative data from 54,867
subjects aged ≥ 20 years with complete data on the
HADS, smoking, and education variables, and without
self-reported previous cardiovascular disease [29]who
participated in the Nord-Trøndelag Health Study 1995-
97 in Norway (the HUNT 2 Study)[30], whereas US
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physical health norms according to SF-36 norm-based
scoring were used, when comparing the physical health
scores in the study with a general population [27]
Statistical analysis
The sample characteristics were summarized by calcu-
lating means, standard deviations (SD) for the continu-
ous variables, and by absolute numbers and percentages
for the categorical variables. Bivariate analyses were per-
formed with paired samples t-tests when comparing
levels of general anxiety and depression in the sample
with the expected scores from the general population,
with one samples t-test to compare physical health in
the sample to US norm scores, and with independent
samples t-test when comparing patient groups.
A series of three hierarchical multiple regression ana-
lyses were conducted to examine avoidance, attention,
and fear entered concurrently, in relation to general
anxiety, depression and physical health. Preliminary ana-
lyses with Spearman rank correlation was estimated to
study the association between variables and to check
that the correlation between the independent variables
(avoidance, attention, and fear) was not too high to
include them as independent determinants in the regres-
sion models.
To investigate the ability of the models (which
includes avoidance, attention, and fear) to predict levels
of general anxiety, depression, and physical health,
beyond relevant demographic covariates (age, gender,
having children) and clinical variables (clinical diagnosis
of either LQTS or HCM, and a recent SCD in the
family), the use of a hierarchical multiple regression
method was justified. The results were reported as
unstandardized regression coefficient (B), standard error
(SE) to investigate the relationship of the independent
variables to the dependent variables, standardized
regression coefficients (beta) to compare the contribu-
tion of each independent value, and F-statistics with p-
values and determination coefficient with R2change were
reported to indicate how much of the overall variance is
explained by our variables of interest after the effects of
relevant socio-demographic and clinical variables. The
unstandardized regression coefficient indicates the
strength of relationship between a given predictor, and
an outcome in the units of measurement of the predic-
tor. It is the change in the outcome associated with a
unit change in the predictor, whereas the standardized
regression coefficient indicates the strength of relation-
ship between a given predictor and an outcome in a
standardized form. It is the change in the outcome (in
standard deviations) associated with a one standard
deviation change in the predictor, thus it is suitable for
comparing the effects of predictors possibly measured
on different scales or in different units of measurement.
All tests were two-tailed at the 5% significance level.
Data were analyzed using SPSS version 15.0.
Results
Sample characteristics
Among the 126 study participants, the mean age was 45
years (SD = 16) and 53% (n = 67) were women. It was
found that 70% of the patients (n = 88) had a LQTS
family history or were affected clinically with LQTS
(familial LQTS group), and 30% of the patients (n = 38)
reported a HCM family history or were affected clini-
cally with HCM (familial HCM group). Seventy-eight
percent of the patients (n = 98) had children, and 28%
of the patients (n = 35) had experienced a SCD in a first
or second degree relative, 20% of the patients (n = 25)
as recent as in the last year. Of the total sample of
patients, 25% (n = 32) had a clinical diagnosis of either
LQTS or HCM as opposed to 75% (n = 94) at genetic
risk because of family history of LQTS or HCM. The
socio-demographic variables of the study population are
more extensively described in a recent publication [31].
Patients level of general anxiety, depression, and physical
health as compared to expected scores of the general
population
In the present sample, the proportion of patients with
clinical HADS scores 8 or greater for general anxiety or
depression were 24.6% (n = 31) and 13.5% (n = 17),
respectively. Whether the patients were at genetic risk
or were diagnosed with LQTS or HCM did not cause
significant differences in levels of general anxiety (mean
difference -0.1, t (-0.1), p = 0.90 (two-tailed)) and
depression (mean difference -0.4, t (-0.5), p = 0.64 (two-
tailed)).
Overall, the study group (n = 125) had significantly
higher levels of general anxiety as compared to expected
scores of the general population (mean difference 1.1, t
(3.2), p < 0.01 (two-tailed)); adjusted for gender, age,
education level, and smoking status), whereas depression
levels were similar to expected scores (mean difference
-0.2, t (0.7), p = 0.50 (two-tailed)). Moreover, physical
health did not differ significantly from expected scores.
However, patients at genetic risk (n = 89) scored better
on physical health as compared to expected scores
(mean difference 2.3, t(3.0), p < 0.01 (two-tailed)),
whereas the patients with clinical diagnosis of either
LQTS or HCM (n = 31) showed poorer physical health
as compared to expected scores (mean difference -4.5 t
(-2.4), p = 0.02 (two-tailed)) (Table 1).
Comparisons between patients with familial LQTS and
patients with familial HCM
When comparing the patients with familial LQTS to
patients with familial HCM, there were no significant
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differences with regard to level of general anxiety and
depression, whereas poorer physical health (mean differ-
ence 4.5, t(2.5), p < 0.01(two-tailed)) and higher scores
of avoidance (mean difference -0.7, t(-4.1), p < 0.01(two-
tailed)), attention (mean difference -0.5, t(-3.6), p <0.01
(two-tailed)), fear (mean difference -0.5, t(-3.3), p < 0.01
(two-tailed)) were found in the latter group.
In the subgroups, patients at genetic risk had higher
fear scores in HCM families as compared to in LQTS
families, whereas there were no significant differences in
the other patient-reported outcomes. Patients with a
clinical diagnosis had poorer physical health and higher
avoidance scores in HCM families as compared to in
LQTS families, whereas significant differences were not
found in level of general anxiety and depression, or in
attention or fear scores. (Table 2).
Correlational analyses
As shown in table 3, there were significant correlation
coefficients between pair-wise comparisons of the
Table 1 General anxiety, depression (HADS), and physical health (PCS) in individuals with familial Long QT syndrome
(LQTS) and Hypertrophic cardiomyopathy (HCM) as compared to expected scores of general population
Patient-reported outcomes n Study sample Norwegian
expected scores*
p-value
HADS- Total sample 125 4.9 (4.0) 3.8 (0.5) <0.01
Anxiety At genetic risk 93 4.9 (3.8) 3.9 (0.5) 0.01
(0-21) With clinical diagnosis 32 5.0 (4.5) 3.7 (0.5) 0.10
HADS- Total sample 125 3.1 (3.7) 2.9 (0.7) 0.50
Depression At genetic risk 93 3.0 (3.8) 2.9 (0.7) 0.65
(0-21) With clinical diagnosis 32 3.4 (3.7) 3.0 (0.8) 0.58
SF36- Total sample 120 50.6 (8.6) 50.0 (10) 0.48
Physical health At genetic risk 89 52.3 (7.2) 50.0 (10) <0.01
Summary
(0-100)
With clinical diagnosis 31 45.5 (10.4) 50.0 (10) 0.02
HADS: Hospital Anxiety and Depression Scale; PCS: SF-36 Physical Component Summary; results are presented as mean (standard deviation), number of
participants and p-values.
*Expected scores, based on Norwegian general population, adjusted to the age, gender, education level, and smoking habits distribution in the sample (n = 125)
Table 2 General anxiety, depression (HADS), physical health (PCS), and heart-focused anxiety (CAQ-avoidance,
-attention and -fear) scores of individuals with familial Long QT syndrome (LQTS) as compared to individuals with
familial Hypertrophic cardiomyopathy (HCM)
Patient-reported outcomes Familial LQTS n Familial HCM n p-value
HADS- Total sample 5.0 (4.1) 87 4.7 (3.8) 38 0.74
Anxiety (0-21) At genetic risk 5.1 (3.9) 75 4.0 (3.5) 18 0.29
With clinical diagnosis 4.3 (5.2) 12 5.3 (4.1) 20 0.54
HADS- Total sample 3.0 (4.0) 87 3.3 (2.9) 38 0.65
Depression (0-21) At genetic risk 3.1 (3.9) 75 2.8 (3.1) 18 0.76
With clinical diagnosis 2.6 (4.8) 12 3.9 (2.9) 20 0.35
SF36- Total sample 52.0 (7.1) 84 47.1 (10.5) 36 0.01
Physical health At genetic risk 52.2 (7.1) 72 52.8 (7.6) 17 0.75
Summary (0-100) With clinical diagnosis 51.0 (8.6) 12 42.1 (10.2) 19 0.02
CAQ- Total sample 0.7 (0.7) 87 1.4 (0.9) 38 <0.01
Avoidance (0-4) At genetic risk 0.8 (0.7) 75 1.1 (0.7) 18 0.06
With clinical diagnosis 0.6 (0.4) 12 1.7 (1.0) 20 <0.01
CAQ- Total sample 0.6 (0.6) 88 1.1 (0.8) 38 0.01
Attention (0-4) At genetic risk 0.6 (0.5) 76 0.8 (0.7) 18 0.11
With clinical diagnosis 0.8 (0.9) 12 1.3 (0.8) 20 0.13
CAQ- Total sample 1.0 (0.8) 87 1.5 (0.7) 38 <0.01
Fear (0-4) At genetic risk 1.0 (0.7) 75 1.4 (0.7) 18 0.05
With clinical diagnosis 1.3 (1.0) 12 1.7 (0.8) 20 0.34
HADS: Hospital Anxiety and Depression Scale; PCS: SF-36 Physical Component Summary; HADS, and Cardiac Anxiety Questionnaire; CAQ are presented as mean
(standard deviation) and number of participants
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independent variables (avoidance, attention, and fear)
and the dependent variables (general anxiety, depression,
and physical health). The most negative and significant
correlation coefficient was between avoidance and physi-
cal health (r = -0.44). Attention and general anxiety (r =
0.45), and fear and depression (r = 0.45) had the most
positive correlation coefficients. Among the independent
variables the strongest correlation coefficient was
between attention and fear (r = 0.66).
Symptoms of heart-focused anxiety independently
related to general anxiety, depression and physical health
Table 4 summarizes the hierarchical regression analysis
for general anxiety, depression, and physical health. In
terms of general anxiety, the variables (gender, age, hav-
ing children, clinical diagnosis of either LQTS or HCM,
recent SCD of a relative) entered at step 1 of the model
accounted for 10% of the variance in general anxiety,
with gender (p < 0.01) and recent SCD (p = 0.04) as sig-
nificant predictors. After entry of the symptoms of
heart-focused anxiety (avoidance, attention, and fear) at
step 2 the total variance explained by the model was
33%, F (8, 114) = 7.06, p < 0.01. The symptoms of
heart-focused anxiety uniquely explained 23% of the var-
iance in general anxiety, R squared change = 0.23, F
change (3,114) = 13.3, p < 0.01. In the final model, gen-
der, recent SCD in the family, avoidance, and fear were
statistical significant, with the fear scale reporting the
highest beta value (beta = 0.32, p < 0.01).
For the depression scale, the control variables in step
1 accounted for 13% of the variance in depression.
Recent SCD in the family was the only variable signifi-
cant (p = 0.03). After entry of the symptoms of heart-
focused anxiety (avoidance, attention, and fear) at step
2, the model as a whole explained 25.8%, F (8, 114) =
5.0, p < 0.01. Apart from the variables controlled for,
the symptoms of heart-focused anxiety explained an
additional 13% in depression, R squared change = 0.13,
F change (3, 114) = 6.7, p < 0.01. In the final model the
Table 3 Spearman correlations between the study
variables
1. 2. 3. 4. 5. 6.
1. CAQ Avoidance - 0.43** 0.46** 0.39** 0.44** -0.44**
2. CAQ Attention - 0.66** 0.45** 0.37** -17.5
3. CAQ Fear - 0.44** 0.45** -0.37**
4. HADS Anxiety - 0.68** -0.27**
5. HADS Depression - -0.40**
6. PCS Physical health -
N 125 126 125 125 125 120
CAQ: Cardiac Anxiety Questionaire; HADS: Hospital Anxiety and Depression
Scale; PCS: SF-36 Physical Component Summary;*p < 0.05; **p < 0.01
Table 4 Hierarchical regression analyses assessing cardio-
protective avoidance (avoidance), heart-focused
attention (attention) and fear about heart sensations
(fear) (CAQ)(scores 0-4) as independent determinants of
general anxiety, depression (HADS) (scores 0-21), and
physical health (PCS) (scores 0-100)
Variables R2
change
B SE
B
b p-
value
Step
1
HADS Anxiety 0.10
Male gender -2.07 0.73 -0.26 <0.01
Age -0.002 0.03 -0.01 0.94
Children 0.29 1.14 0.03 0.80
Diagnosis 0.90 0.84 0.10 0.29
Recent SCD in the
family
1.93 0.92 0.19 0.04
Step
2
Male gender 0.23 -1.57 0.64 -0.20 0.02
Recent SCD in the
family
1.79 0.80 0.18 0.03
Avoidance 1.09 0.45 0.22 0.02
Attention 0.40 0.62 0.07 0.52
Fear 1.65 0.54 0.32 <0.01
Step
1
HADS Depression 0.13
Gender -0.70 0.66 -0.09 0.29
Age 0.05 0.03 0.20 0.09
Children 0.83 1.04 0.09 0.43
Diagnosis 0.71 0.77 0.08 0.36
Recent SCD in the
family
1.83 0.84 0.20 0.03
Step
2
0.13
Recent SCD in the
family
1.72 0.79 0.18 0.03
Avoidance 0.93 0.45 0.21 0.04
Attention -0.45 0.61 -0.08 0.46
Fear 1.42 0.53 0.30 <0.01
Step
1
PCS Physical health 0.24
Male gender 2.23 1.46 0.13 0.13
Age -0.22 0.06 -0.41 <0.01
Children 2.19 2.30 0.10 0.34
Diagnosis -6.47 1.70 -0.33 <0.01
Recent SCD in the
family
0.69 1.84 0.03 0.71
Step
2
19.4
Age -0.15 0.05 -0.28 <0.01
Diagnosis -4.29 1.57 -0.22 <0.01
Avoidance -4.00 0.92 -0.38 <0.01
Attention 2.15 1.25 0.17 0.09
Fear -2.89 1.09 -0.26 <0.01
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following variables were significant; recent SCD in the
family, avoidance, and fear, with the fear scale reporting
a higher value (beta = 0.30, p < 0.01).
With regard to physical health, the variables (gender,
age, having children, clinical diagnosis of either LQTS
or HCM, recent SCD in the family) entered at step 1 of
the model accounted for 24% of the variance in physical
health. Increasing age (p < 0.01) and clinical diagnosis
of either LQTS or HCM (p < 0.01) were significant pre-
dictors. After entry of the symptoms of heart-focused
anxiety (avoidance, attention, and fear) at step 2 the
total variance explained by the model was 44%, F (8,
109) = 10.6, p < 0.01. The symptoms of heart-focused
anxiety explained an additional 19% in physical health
after controlling for step 1 variables, R squared change
= 0.19, F change (3,109) = 12.5, p < 0.01. In the final
model age, clinical diagnosis, avoidance, and fear were
statistical significant, with the avoidance scale reporting
the highest beta value (-0.38, p < 0.01).
Discussion
The present study aimed to investigate the role of three
distinct symptoms of heart-focused anxiety (avoidance,
attention, and fear), in relation to general anxiety,
depression and physical health in patients referred to
cardio-genetic counseling and at higher risk than the
average person for serious arrhythmias and SCD because
of a personal or a family history of an inherited cardiac
disorder (familial LQTS or familial HCM). First, the
levels of general anxiety, depression, and physical health
in the patients were investigated in comparison to
expected scores of the general population, further, the
scores of general anxiety, depression, physical health,
and heart-focused anxiety of patients with familial
LQTS were compared to the scores of patients with
familial HCM, and finally, the independent influence of
avoidance, attention, and fear were examined in relation
to general anxiety, depression, and physical health.
General anxiety, depression, physical health, and heart-
focused anxiety
High levels of general anxiety may be one of the major
psychological problems among patients referred to
genetic counseling for inherited cardiac disorders. In
this study, approximately one quarter of the sample had
clinical anxiety symptoms, whereas 13.5% scored above
cut-off for depression. Further, the mean general anxiety
scores were found to be significantly higher in the
patients as compared to expected scores of the general
population, whereas there were no significant differences
in depression scores. The same pattern was found when
analyzing patients at genetic risk in comparison to
expected scores, this in contrast to previous findings
among HCM mutation carriers without manifest disease
[11], and in LQTS carriers without abnormal ECG [12].
In the previous reports, baseline data (i.e. before the
patients had attended genetic counseling) were not ana-
lyzed, as in the present study, which may have biased
their findings [11,12]. In addition, when comparing gen-
eral anxiety and depression scores in patients with
familial LQTS to familial HCM no significant differences
were found, which was somewhat unexpected since pre-
vious research on patients with familial HCM especially
has identified poor health-related quality of life in both
mental an physical domains [16]. This may suggest that
the overall level of general anxiety before receiving
genetic counseling is determined by other factors than
disease status or the inherited cardiac disorder in ques-
tion in the present sample. Heart-focused anxiety may
be one of the important reasons for elevated general
anxiety in patients referred to genetic investigation and
counseling for familial LQTS or familial HCM. Com-
mon for the patients with familial LQTS and familial
HCM receiving genetic investigation and counseling, is
a disease threat that runs in the family. The patients
may have experienced other family members’ disease or
have a family history of SCD, factors that are known to
cause high levels of heart-focused anxiety [31]. For
example, in the present sample 28% of the patients had
experienced a sudden cardiac death in a first or second
degree relative. Patients with this experience and
patients uncertain whether other relatives had under-
gone genetic testing had higher levels of heart-focused
anxiety up to one year after genetic counseling, whereas
satisfaction with the procedural parts of genetic counsel-
ing predicted decreased levels of heart-focused anxiety
over time [23]. Therefore, it is possible that satisfaction
with genetic counseling also will lead to decreased levels
of general anxiety, however the different subgroups may
show different patterns with that, as previous research
has indicated[11,12].
In the present study, patient-reported physical health
was overall as expected in a general population. How-
ever, physical health differed according to disease status.
As expected, patients with a clinical diagnosis of either
LQTS or HCM reported poorer physical health com-
pared to expected scores of the general population,
whereas patients at genetic risk reported somewhat bet-
ter physical health. The manifestation of cardiac symp-
toms may be more likely in the group that already have
been diagnosed, especially among the patients with
HCM, who in addition to the risk of arrhythmias, can
Abbrev: B: unstandardized coefficients; SE: Standard error; b: standardized
regression coefficients; R2 change: determination coefficient change
HADS: Hospital Anxiety and depression scale; PCS: SF-36 Physical Component
Summary; Diagnosis: Clinical diagnosis of Long QT syndrome or Hypertrophic
cardiomyopathy; SCD: Sudden Cardiac Death
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experience quite debilitating cardiac symptoms, which is
the most likely explanation of the poorer physical health
reported. This was further supported in the subgroup
analyses. However, patients at genetic risk also have a
substantial risk of having inherited the condition (50%
for first-degree relatives), and thus a significant risk that
sensations and stimuli from the heart can be potentially
life threatening, which is a possible explanation why
they presented with similar elevated general anxiety
levels as the patients with a clinical diagnosis. However,
we did not expect that they would report better physical
health than the general population, but this phenom-
enon has been previously observed in similar popula-
tions [11], and may be caused by confounding factors
such as younger age in the sample as compared to that
of the norm population, or again, the experience of
family members’ illness, or SCD may cause individuals
to value their own health more.
Symptoms of heart-focused anxiety independently
related to general anxiety, depression, and physical
health
To address the overall aim of the study, the question
posed is to what extent levels of general anxiety, depres-
sion, and physical health could have been independently
influenced by the three distinct symptoms of heart-
focused anxiety (avoidance, attention, and fear).
Partially consistent with the hypothesis, the result
showed that avoidance and fear were symptoms of
heart-focused anxiety that were significantly related to
general anxiety, depression, and physical health, but
attention was not. Specifically, patients who had higher
levels of avoidance and fear were more likely to report
higher levels of general anxiety, depression, and poorer
physical health. A somewhat larger effect was observed
for fear compared to avoidance in predicting general
anxiety and depression, whereas avoidance had a stron-
ger association to physical health.
The interpretation of the role of avoidance is not
straight forward. Cardio-protective avoidance has been
described as one of the cardinal symptoms of heart-
focused anxiety [17,32,33]. Besides the fact that our
findings showed that avoidance was uniquely related to
general anxiety and depression, it is in fact one of the
recommendations to this patient group [8]. “Cardio-pro-
tective avoidance” may equate to good patient adherence
to appropriate medical recommendations. That is, a
patient who has been given a diagnosis or are at genetic
risk of either LQTS or HCM will often be coached to
avoiding competitive athletic activity to prevent arrhyth-
mia or sudden cardiac death, as cardio- protective
avoidance. Avoidance of such activities does in that case
not signify fearful symptoms, rather, appropriate adjust-
ments to the limitations imposed by the disease, in line
with our finding that higher avoidance scores is strongly
related to poorer physical health, beyond the effects of
gender, age, having children, clinical diagnosis and a
recent SCD of a relative, as well as fear and attention.
Interestingly, even if avoidance may be perceived as a an
adaptive coping response or as a preventive measure,
avoidance is also strongly related to higher levels of gen-
eral anxiety and depression, which indicates that avoid-
ance includes more than being an adaptive coping
response. Thus, the current findings suggest that avoid-
ance may be part of a psychological process highly influ-
ential in the production of general anxiety and
depression, in addition to its relation to poorer patient-
reported physical health.
This has implications for the genetic counseling of
these patients. By addressing avoidance in the patient,
the counselor will have access to important information
to target intervention, and can provide information
about that normal activities are not harmful. This may
be important to prevent a vicious circle for the patients
since avoidance may disrupt not only physical activity
but also social life and occupational life functioning if
such avoidance escalates [33]. In predicting avoidance, a
mutation negative result was related to decreased avoid-
ance [23]. Information about consequences of genetic
testing may therefore be of influence, since a mutation
positive test result will emphasize certain activity restric-
tions, while a negative more or less can rule out the
recommendations.
Addressing fear of SCD is according to genetic coun-
seling literature the main concern of psychological
counseling in LQTS and HCM patients [13]. Results
from the hierarchical regression analyses show that
besides from significant effects of recent SCD in the
family and cardio-protective avoidance, fear about heart
sensations is the symptom that is strongest associated to
general anxiety and depression, giving support to that
this is a concern also to be reckoned with in genetic
counseling of these patients. This tally also with pre-
vious research which found that perceived risk of SCD
were associated with higher levels of general anxiety,
depression and poorer physical health and that per-
ceived risk of symptoms were associated with impaired
mental health [11].
In contrast to the two other symptoms, heart- focused
attention did not make a unique contribution in
explaining the health outcomes even if attention was
strongly correlated to general anxiety in particular. This
may be due to the high intercorrelation with fear.
Finally, gender, age, presence of a diagnosis of LQTS or
HCM, and a relative’s recent SCD, made significant con-
tributions to the final models. In line with research of
anxiety and gender, male gender was associated to less
anxiety [34]. Not surprisingly, increasing age and clinical
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diagnosis of either LQTS or HCM was related to poorer
physical health, and finally, a recent SCD in the family
was related to higher levels of general anxiety and
depression.
Study limitations and strenghts
The design of this study shares the limitations that all
cross-sectional designs have regarding control, causality
and generalizability. Our sample size was relatively
small, but the data was, however, collected at three dif-
ferent hospitals in three different health regions of Nor-
way to reduce possible influence of community
characteristics. The two patient groups (i.e. patients with
familial LQTS and patients with familial HCM) differ
from each other in some characteristics; however in the
genetic counseling setting it is interesting to analyze
them together since they are very similar with regard to
the risk they are living with, they share some common
disease manifestations, and LQTS and HCM are both
autosomal dominant disorders with variable penetrance
and disease expression. An important issue in discussing
the findings in the present study is whether the research
sample is representative of a greater population and
what kind of biases might influence the results. Ideally
we would like to generalize the findings in our study to
all subjects undergoing genetic counseling for LQTS
and HCM. The proportion of decliners in the study was
26.6%. The Regional Committee for Medical and Health
Research Ethics did not allow collecting information for
individuals who did not consent to research. Therefore,
it was not possible to compare respondents from non-
respondents. The comparison of general anxiety and
depression scores with expected scores of the general
population was a clear strength of study, since assessing
symptoms based only on cut-off points may be of little
clinical significance.
Finally, the study group consisted of both patients
with a clinical diagnosis and patients at genetic risk,
which can be regarded as very different groups. How-
ever, controlling for this in the analyses showed that
this was meaningful for the study’s findings, as it was
confirmed that being clinically affected only had a sig-
nificant relationship to patient-reported physical health,
whereas it did not relate to levels of general anxiety and
depression.
Conclusion
In summary, the present study demonstrated higher
general anxiety levels among the patients compared to
expected scores of the general population. One fourth of
the patients were clinically anxious, and 28% of the
patients had experience of SCD among first or second
degree relatives, 20% of the patients as recent as in the
last year. General anxiety and depression levels seemed
to be unrelated to having a clinical diagnosis. A more
likely reason for the raised general anxiety level may be
that living with the genetic risk of a life-threatening dis-
order and the uncertainty regarding cardiac symptoms
causes raised levels of general anxiety, especially in
patients with higher levels of heart-focused anxiety. Sup-
porting our hypothesis, it was found that cardio -protec-
tive avoidance and fear about heart sensations may be
part of a psychological process that appear to raise levels
of general anxiety, depression, in addition to that it is
related to poorer patient-reported physical health.
The prediction of risk, information of treatment stra-
tegies and preventive measures is well established in the
genetic counseling method. This finding might therefore
be of particularly clinical interest since it might
strengthen the message that the genetic counseling of
inherited cardiac disorders should be optimized with
respect to not only helping the patients reducing danger
of heart-related events by identifying who is at risk, but
balancing it with the motive of helping the patients to
manage avoidance behavior to minimize cardiac symp-
toms or complications, increased levels of heart-focused
attention and monitoring of cardiac related stimuli, and
fear and worries about heart-sensations and functioning.
The possibilities of genetic testing can give more cer-
tainty as to that their perception of health is accurate,
and counseling can influence more adaptive coping
responses and health outcome. Future research should
explore further whether factors related to genetic inves-
tigation influences symptoms of heart-focused anxiety.
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